Physician profile
Chadd Dee Nelson
NPI 1619904679
$1,210.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $187 · 2021: $11.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.09 | 2019-2020 | |
| Amgen INC. | $123.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $117.96 | 2019 | |
| Glaxosmithkline, LLC. | $105.44 | 2019-2020 | |
| Pfizer INC. | $95.33 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $86.02 | 2019-2020 | |
| Novo Nordisk INC | $85.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.59 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $59.36 | 2019-2020 | |
| Astellas Pharma US INC | $56.32 | 2019-2020 | |
| Lilly USA, LLC | $49.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $38.74 | 2019 | |
| Strongbridge US INC. | $33.72 | 2019 | |
| Shire North American Group INC | $31.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.28 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $18.61 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.87 | 2019 | |
| Dynavax Technologies Corporation | $15.04 | 2019 | |
| Merck Sharp & Dohme LLC | $11.73 | 2019 | |
| Abbott Laboratories | $11.65 | 2021 | |
| Genentech USA, INC. | $11.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadd Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.